Leflunomide in Previously Treated Metastatic Triple Negative Cancers
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
SOLTI Breast Cancer Research Group
H. Lee Moffitt Cancer Center and Research Institute
NeoImmuneTech
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
University of Wisconsin, Madison
Institut Cancerologie de l'Ouest
University of Alabama at Birmingham
Hoffmann-La Roche
SCRI Development Innovations, LLC
I-Mab Biopharma US Limited
Seagen Inc.
Memorial Sloan Kettering Cancer Center
MedSIR
Providence Health & Services
Institut Curie
Merck Sharp & Dohme LLC
Hoffmann-La Roche
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Hummingbird Bioscience
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
National Cancer Centre, Singapore
Institut Curie
Alliance for Clinical Trials in Oncology
Beni-Suef University
Incyte Corporation
Merck Sharp & Dohme LLC
Pure Biologics S.A.
Xencor, Inc.
TransThera Sciences (Nanjing), Inc.
Sun Yat-sen University
Fudan University
Incyte Corporation
Genentech, Inc.
Mayo Clinic
Emory University
Novartis
TransThera Sciences (Nanjing), Inc.
National Cancer Institute (NCI)
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Shanghai Jiaolian Drug Research and Development Co., Ltd
Exelixis
Queen Mary University of London
Ohio State University Comprehensive Cancer Center
BeiGene